Philadelphia, PA – December 10, 2009 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has received approvals from the U.S. Food and Drug Administration (FDA) of its...

Philadelphia, PA – November 23, 2009 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that President and Chief Executive Officer Arthur Bedrosian will ring the opening bell at...

Philadelphia, PA – November 20, 2009 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that its Board of Directors has approved a reauthorization of the stock repurchase...

Fiscal 2010 First-Quarter Highlights: Net sales up 23% to $31.4 million from $25.6 million in the fiscal 2009 first quarter Gross profit grew to $11.5 million compared with $9.0 million in the...

Philadelphia, PA – November 4, 2009 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced that the company will release its fiscal 2010...

Philadelphia, PA – October 14, 2009 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced the appointment of Keith R. Ruck as vice...

Philadelphia, PA – October 2, 2009 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced that it has filed a $150 million universal shelf...

Full-Year Fiscal 2009 Highlights: Net sales up 64% to $119.0 million from $72.4 million in fiscal 2008 Gross profit increased to $45.2 million from $16.3 million in prior year Net income was $6.5...

Philadelphia, PA – September 8, 2009 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced the appointment of Stephen J. Kovary as vice...

Philadelphia, PA – July 16, 2009 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced that William Farber has resumed the role as...

Philadelphia, PA – June 22, 2009 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced that the company’s shares have been added to the...

Philadelphia, PA – June 9, 2009 – Lannett Company, Inc. (AMEX: LCI), a manufacturer of generic pharmaceuticals, today announced the appointment of Terence D. Vollrath as executive vice...

Philadelphia, PA – April 2, 2009 – Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, said today that it is prepared to supply the U.S. market with an...

Philadelphia, PA – April 1, 2009 – Lannett Company, Inc. (NYSE Amex: LCI) today said that it will continue to manufacture and market its Morphine Sulphate products, while it works with...

Philadelphia, PA – March 26, 2009 – Lannett Company, Inc. (NYSE Amex: LCI) today announced that Brian Kearns has resigned as chief financial officer effective March 23, 2009. The...

Lannet (LCI) utilizes Capital Returns, Inc. and incurs the cost of processing and destruction of products returned to Capital Returns. LCI wil not assume responsibility for charges incurred by...